Skip to main
TCRX
TCRX logo

TScan Therapeutics (TCRX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy TScan Therapeutics (TCRX) Stock

About TScan Therapeutics (TCRX)

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge,...read more
Market cap$81.49M
Today's volume119.89K
Revenue (TTM)$4.42M
Avg. daily volume562.77K
EBITDA (TTM)-$136.17M
Open$1.41
Price / earnings ratio-1.32x
Today's range$1.41 - $1.51
Debt / equity46.16x
52 week range$1.02 - $7.89
5 year debt / equity43.17x
Beta (LTM)1.02x
Interest coverage-36.91x
Dividend & yield$0.00 (0.00%)
Current ratio8.55x
Ex-dividend date
Next earningsAug 11, 2025
Dividend payable date

TScan Therapeutics Stock Rating

What analysts recommend for TCRX stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 22, 2025, the market cap for TCRX stock is $81.5M

The current P/E ratio for TCRX stock is -1.32

The 52-week high for TCRX stock is $7.89. The current TCRX stock price $undefined is 100.00% below its 52-week high

The 52-week low for TCRX stock is $1.02. The current TCRX stock price $undefined has increased 100.00% from its 52-week low

No, the TCRX stock does not pay dividends to its shareholders

The target price for TCRX stock is $10.71 based on the average of what a group of analyst think TCRX stock could be worth at a future date. This is not a prediction by Public.com

How to buy TCRX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in TCRX stock

    Navigate to the Explore page. Then, type TCRX into the search bar. When you see TCRX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased TCRX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

TScan Therapeutics Stock Earnings

The value each TCRX share was expected to gain vs. the value that each TCRX share actually gained.

TScan Therapeutics (TCRX) reported Q1 2025 earnings per share (EPS) of -$0.26, beating estimates of -$0.28 by 7.14%. In the same quarter last year, TScan Therapeutics's earnings per share (EPS) was -$0.32. TScan Therapeutics is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of -$0.32.

Buy TScan Therapeutics (TCRX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.